Literature DB >> 10409694

Mutational analysis of the hydrolytic activity of yeast RNA polymerase III.

E V Bobkova1, N Habib, G Alexander, B D Hall.   

Abstract

For 25 mutant alleles of ret1, encoding the second largest subunit of yeast RNA polymerase III, we have studied the polymerase III nuclease activity, measuring both the total yield and dinucleotide product composition. Mutations affecting amino acids 309-325 gave slightly elevated nuclease activity. In region 367-376, two mutations gave 12-15-fold increased nuclease activity. Our results do not support the catalytic role in nuclease activity proposed for the conserved DDRD motif in this region (Shirai, T., and Go, M. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 9056-9060). Mutations centered on a basic region from amino acids 480 to 490, which aligns with Escherichia coli beta-subunit sequences between Rif(r) clusters I and II, produce changes in the relative yields of A- and G-containing dinucleotides. Four such mutant polymerases pause during elongation at GPy sequences and, in addition, have a reduced frequency of termination at T(5) terminator sequences. We propose that the side chains of these mutationally altered amino acids are in direct contact with bases in the RNA-DNA hybrid very near the growing 3'-end. Two mutations in domain I near the C terminus produced very large increases in exonuclease activity and strongly increased termination, suggesting that this region also contacts the nascent RNA in the hybrid region.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10409694     DOI: 10.1074/jbc.274.30.21342

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  A genetic look at the active site of RNA polymerase III.

Authors:  S Rozenfeld; P Thuriaux
Journal:  EMBO Rep       Date:  2001-07-03       Impact factor: 8.807

Review 2.  La protein and its associated small nuclear and nucleolar precursor RNAs.

Authors:  Richard J Maraia; Robert V Intine
Journal:  Gene Expr       Date:  2002

Review 3.  Comparison of the RNA polymerase III transcription machinery in Schizosaccharomyces pombe, Saccharomyces cerevisiae and human.

Authors:  Y Huang; R J Maraia
Journal:  Nucleic Acids Res       Date:  2001-07-01       Impact factor: 16.971

Review 4.  Structural perspective on mutations affecting the function of multisubunit RNA polymerases.

Authors:  Vincent Trinh; Marie-France Langelier; Jacques Archambault; Benoit Coulombe
Journal:  Microbiol Mol Biol Rev       Date:  2006-03       Impact factor: 11.056

Review 5.  Comparative overview of RNA polymerase II and III transcription cycles, with focus on RNA polymerase III termination and reinitiation.

Authors:  Aneeshkumar G Arimbasseri; Keshab Rijal; Richard J Maraia
Journal:  Transcription       Date:  2014

6.  Distinguishing core and holoenzyme mechanisms of transcription termination by RNA polymerase III.

Authors:  Aneeshkumar G Arimbasseri; Richard J Maraia
Journal:  Mol Cell Biol       Date:  2013-02-11       Impact factor: 4.272

Review 7.  A methods review on use of nonsense suppression to study 3' end formation and other aspects of tRNA biogenesis.

Authors:  Keshab Rijal; Richard J Maraia; Aneeshkumar G Arimbasseri
Journal:  Gene       Date:  2014-11-18       Impact factor: 3.688

8.  Mutations in the RNA polymerase III subunit Rpc11p that decrease RNA 3' cleavage activity increase 3'-terminal oligo(U) length and La-dependent tRNA processing.

Authors:  Ying Huang; Robert V Intine; Amy Mozlin; Samuel Hasson; Richard J Maraia
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

Review 9.  Transcription termination by the eukaryotic RNA polymerase III.

Authors:  Aneeshkumar G Arimbasseri; Keshab Rijal; Richard J Maraia
Journal:  Biochim Biophys Acta       Date:  2012-10-23

10.  RNA polymerase III mutants in TFIIFα-like C37 that cause terminator readthrough with no decrease in transcription output.

Authors:  Keshab Rijal; Richard J Maraia
Journal:  Nucleic Acids Res       Date:  2012-10-23       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.